GEHC
GE HEALTHCARE TECHNOLOGIES INC.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus- 売上
- $20.6bn
- 時価総額
- $32.0bn
株価 $69.94 · 100株 6,994円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $19.6bn | $19.7bn | $20.6bn |
| 成長率 | — | 0.6% | 4.8% |
| 総利益 | $7.9bn | $8.2bn | $8.2bn |
| 総利益率 | 40.5% | 41.7% | 40.0% |
| 販管費 | $4.3bn | $4.3bn | $4.2bn |
| 販管費率 | 21.9% | 21.7% | 20.5% |
| 営利 | $2.4bn | $2.6bn | $2.8bn |
| 営利率 | 12.5% | 13.3% | 13.4% |
| 純利益 | $1.6bn | $2.0bn | $2.1bn |
| PBR | 4.5 | 3.8 | 3.1 |
| PSR | 1.6 | 1.6 | 1.6 |
| PGPR | 4.0 | 3.9 | 3.9 |
| PER | 20 | 16 | 15 |
| ﾈｯﾄｷｬｯｼｭ | ▲$6.9bn | ▲$6.1bn | ▲$5.5bn |
| EV/EBITDA | 12.8 | 11.9 | 11.2 |
| Rule of 40 | — | 14% | 18% |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）